Freenome, Inc. - Common stock (FRNM)

11.01
-0.14 (-1.26%)
NASDAQ· Last Trade: Aug 4th, 2:15 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close11.15
Open11.15
Bid11.10
Ask11.44
Day's Range10.86 - 11.52
52 Week Range9.970 - 14.26
Volume755,295
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume802,817

Chart

News & Press Releases

FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
– Approval expands colorectal cancer screening options for the up to 60 million Americans who are overdue for screening –
By Freenome, Inc. · Via GlobeNewswire · July 27, 2026